🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT03797482
Recruiting Observational

A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer

NCT03797482 · tracked via the Priya Life Science India tracker
Sponsor
Tata Memorial Hospital
Phase
Observational
Started
2017-11-27
Last updated
2025-09-10

Condition(s) studied

Breast Cancer Female

Investigational drug(s) / intervention(s)

Intra-operative Tumor Tissue Biopsy

Intra-operative Tumor Tissue Biopsy: The changing pattern of gene expression during surgery has never been studied. This could be an effect of acute hypoxia that sets in the tumour during surgery or could be a surgical response. To study these changes happening in the tumour during surgery, we are taking serial biopsies during surgery, one at the beginning, one midway during surgery and one at the end of surgery. These samples will be snap frozen and stored at -80 deg celsius in biorepository for future analysis.

Study summary

To understand the effects induced by acute hypoxia that sets in during surgery in breast cancer. To study this, clinical samples (Tumor biopsies) will be obtained during the surgery after partial devascularisation (sample B) and stored for future genomic and proteonomic evaluations.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Clinically diagnosis of breast cancer (by FNAC or Biopsy) 2. Not received any chemotherapy or surgical intervention except core biopsy. 3. Planed for Breast cancer surgery 4. Willing to give consent for the study Exclusion Criteria: 1. Clinically diagnosis of Metastatic breast cancer 2. Received any anticancer therapy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tata Memorial Center Mumbai Maharashtra Recruiting

More Tata Memorial Hospital trials in India

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03797482 on ClinicalTrials.gov ↗ ← All trials in India